dNovo Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $2.7M

  • Investors
  • 15

dNovo General Information

Description

Developer of cell-maintained technology designed to solve hair loss problems by making new stem cells with direct reprogramming technology. The company's platform utilizes conversion of adult human cells, such as skin, blood, or fat cells, into new stem cells to replenish depleted or dysfunctional stem cell populations associated with aging, enabling clients to replace the cells and provide healthy lifestyles.

Contact Information

Website
www.dnovobio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5941 Optical Court
  • San Jose, CA 95138
  • United States
Primary Industry
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 5941 Optical Court
  • San Jose, CA 95138
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

dNovo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 24-Jan-2022 $2.7M Completed Pre-Clinical Trials
2. Seed Round 01-Oct-2019 Completed Stealth
1. Accelerator/Incubator 01-Jul-2018 $125K $125K Completed Stealth
To view dNovo’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

dNovo Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

dNovo Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4419648-A1 Transdifferentiation of non-dermal papilla cells to dermal papilla cells Inactive 20-Oct-2021
US-20250002848-A1 Transdifferentiation of non-dermal papilla cells to dermal papilla cells Pending 20-Oct-2021
WO-2023070026-A1 Transdifferentiation of non-dermal papilla cells to dermal papilla cells Inactive 20-Oct-2021
US-20250002849-A1 Transdifferentiation of non-hair follicle stem cells to non-auditory induced hair follicle stem cells Pending 01-Sep-2021
WO-2023034910-A1 Transdifferentiation of non-hair follicle stem cells to non-auditory induced hair follicle stem cells Inactive 01-Sep-2021 C12N5/0628
To view dNovo’s complete patent history, request access »

dNovo Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

dNovo Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ataria Venture Capital Minority
Angel (individual) Minority
Angel (individual) Minority
Duro Ventures Venture Capital Minority
Felicis Venture Capital Minority
You’re viewing 5 of 15 investors. Get the full list »

Ready to get started?

Request a free trial

dNovo FAQs

  • When was dNovo founded?

    dNovo was founded in 2018.

  • Where is dNovo headquartered?

    dNovo is headquartered in San Jose, CA.

  • What is the size of dNovo?

    dNovo has 4 total employees.

  • What industry is dNovo in?

    dNovo’s primary industry is Biotechnology.

  • Is dNovo a private or public company?

    dNovo is a Private company.

  • What is dNovo’s current revenue?

    The current revenue for dNovo is .

  • How much funding has dNovo raised over time?

    dNovo has raised $2.83M.

  • Who are dNovo’s investors?

    Ataria, , , Duro Ventures, and Felicis are 5 of 15 investors who have invested in dNovo.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process